Lauterbach Sandra Leigh 4
4 · Protalix BioTherapeutics, Inc. · Filed Jul 18, 2012
Insider Transaction Report
Form 4
Lauterbach Sandra Leigh
VP, Sales & Commercial Affairs
Transactions
- Award
Common Stock
2012-07-16+20,000→ 20,000 total(indirect: By Trust)
Footnotes (1)
- [F1]Represents restricted shares of common stock of Protalix BioTherapeutics, Inc., issued under its 2006 Stock Incentive Plan, as amended June 17, 2012. The restricted shares vest in 12 equal quarterly increments over a three-year period, commencing on the date of grant.